Onkọwe Ọkunrin: William Ramirez
ỌJọ Ti ẸDa: 18 OṣU KẹSan 2021
ỌJọ ImudojuiwọN: 1 OṣU KẹRin 2025
Anonim
RESVERATROL & PTEROSTILBENE | Why I Stopped Taking Them
Fidio: RESVERATROL & PTEROSTILBENE | Why I Stopped Taking Them

Akoonu

Resveratrol jẹ kẹmika ti a ri ninu ọti-waini pupa, awọn awọ eso ajara pupa, oje eso ajara eleyi ti, mulberries, ati ni awọn iwọn ti o kere ju ninu epa. O ti lo bi oogun.

Resveratrol jẹ lilo pupọ julọ fun idaabobo awọ giga, akàn, aisan ọkan, ati ọpọlọpọ awọn ipo miiran. Sibẹsibẹ, ko si ẹri ti o lagbara lati ṣe atilẹyin fun lilo resveratrol fun awọn lilo wọnyi.

Awọn Ile-ẹkọ Iṣeduro Alaye Awọn Oogun Adayeba awọn oṣuwọn doko da lori ẹri ijinle sayensi ni ibamu si iwọn wọnyi: Imudara, O ṣeeṣe Ki o munadoko, O ṣeeṣe Ki o munadoko, O ṣeeṣe Ki o munadoko, O ṣeeṣe pe ko wulo, ko wulo, ati Ẹri ti ko to lati Oṣuwọn.

Awọn igbelewọn ṣiṣe fun RESVERATROL ni atẹle:

O ṣee ṣe ki o munadoko fun ...

  • Iba. Lilo ifunra imu ti o ni resveratrol ni igba mẹta lojoojumọ fun ọsẹ mẹrin 4 dabi pe o dinku awọn aami aiṣan ti ara korira ninu awọn agbalagba pẹlu awọn nkan ti ara korira akoko. Lilo itọ imu ti o ni resveratrol ati beta-glucans ni igba mẹta lojoojumọ fun awọn oṣu 2 tun dabi pe o dinku awọn aami aiṣan ti ara korira ninu awọn ọmọde pẹlu awọn nkan ti ara korira akoko.
  • Isanraju. Diẹ ninu iwadi ṣe afihan pe gbigba resveratrol le mu pipadanu iwuwo pọ si awọn agbalagba ti o sanra.

O ṣee ṣe ki o munadoko fun ...

  • Arun okan. Awọn eniyan ti o gba iye ti o ga julọ ti resveratrol ti ounjẹ ko dabi pe o ni eewu kekere ti aisan ọkan ni akawe si awọn eniyan ti o jẹ iye kekere. Pẹlupẹlu, gbigba resveratrol nipasẹ ẹnu ko dabi lati mu awọn ipele ti idaabobo awọ pọ tabi awọn ọra ẹjẹ ti a pe ni triglycerides ninu awọn eniyan ti o wa ni eewu fun aisan ọkan.
  • Kikojọ awọn aami aisan ti o mu eewu ti àtọgbẹ, arun ọkan, ati ikọlu ṣiṣẹ (iṣọn ara ijẹ-ara). Gbigba resveratrol ko dabi ẹni pe o dinku titẹ ẹjẹ, suga ẹjẹ, tabi idaabobo awọ ninu awọn eniyan ti o ni iṣọn ti iṣelọpọ. Iwadi ni kutukutu fihan pe resveratrol le ṣe iranlọwọ lati dinku iwuwo ara ati ọra ara ni awọn eniyan ti o ni iṣọn-ara ti iṣelọpọ. Ṣugbọn a nilo iwadi diẹ sii lati jẹrisi.
  • Kọ ọra ninu ẹdọ ni awọn eniyan ti o mu diẹ tabi ko si ọti-lile (aisan ẹdọ ti ko ni ọti-lile tabi NAFLD). Ọpọlọpọ iwadii ni kutukutu fihan pe resveratrol ko ṣe ilọsiwaju iṣẹ ẹdọ, ọgbẹ ẹdọ, tabi awọn ipele idaabobo awọ ninu awọn eniyan ti o ni NAFLD.

Ẹri ti ko to lati ṣe iṣiro oṣuwọn fun ...

  • Irorẹ. Iwadi ni kutukutu fihan pe lilo gel ti o ni resveratrol si oju fun awọn ọjọ 60 dinku idibajẹ irorẹ.
  • Kọ silẹ ni iranti ati awọn ọgbọn ero ti o waye deede pẹlu ọjọ-ori. O jẹ koyewa ti resveratrol ṣe iranlọwọ pẹlu iranti tabi awọn ọgbọn ero ninu awọn eniyan agbalagba. Diẹ ninu iwadii ni kutukutu fihan pe resveratrol le mu awọn ọgbọn ironu ati iranti wa ninu awọn obinrin lẹyin ti ọkunrin ba ti ṣe nkan oṣu. Ṣugbọn iwadi miiran fihan pe resveratrol ti a fun ni awọn abere to ga julọ tabi fun akoko to gun ko ni mu iranti dara sii tabi awọn ọgbọn ero ni awọn agbalagba agbalagba ilera.
  • Ẹjẹ ẹjẹ ti o dinku awọn ipele ti amuaradagba ninu ẹjẹ ti a pe ni haemoglobin (beta-thalassaemia). Iwadi ni kutukutu fihan pe gbigbe trans-resveratrol ko mu awọn ipele hemoglobin dara si tabi iwulo fun gbigbe ẹjẹ ni awọn eniyan ti o ni beta-thalassaemia.
  • Akàn. Awọn eniyan ti o gba iye ti o ga julọ ti resveratrol ti ounjẹ ko dabi pe o ni eewu kekere ti akàn ni akawe si awọn eniyan ti o jẹ iye kekere.
  • Àtọgbẹ. Diẹ ninu awọn iwadii fihan pe resveratrol ṣe ilọsiwaju iṣakoso suga ẹjẹ ninu awọn eniyan ti o ni àtọgbẹ. Ṣugbọn iwadi miiran ko fihan anfani kankan. Resveratrol le ṣe iranlọwọ lati dinku suga ẹjẹ ni awọn alaisan nikan pẹlu awọn ipele suga ẹjẹ ti ko ni iṣakoso daradara. A nilo iwadi diẹ sii lati jẹrisi.
  • Ibajẹ Kidirin ninu awọn eniyan ti o ni àtọgbẹ (nephropathy dayabetik). Iwadi ni kutukutu fihan pe gbigba resveratrol pẹlu oogun losartan le mu ilọsiwaju diẹ ninu awọn igbese ti ibajẹ akọn ni awọn eniyan ti o ni nephropathy dayabetik lọ.
  • Aarun ẹdọfóró ti o mu ki o nira lati simi (arun onibaje ti o ni idiwọ tabi COPD). Iwadi ni kutukutu daba pe gbigbe ọja apapọ kan ti o ni resveratrol, Vitamin C, zinc, ati flavonoids din diẹ ni ikọ ati iṣelọpọ imukuro ni awọn eniyan ti o ni COPD. Ṣugbọn ko ṣe kedere ti anfaani naa jẹ nitori resveratrol tabi awọn eroja miiran.
  • Osteoarthritis. Iwadi ni kutukutu fihan pe fifi resveratrol si awọn itọju deede fun osteoarthritis orokun le mu ilọsiwaju dara, iṣẹ, ati lile diẹ sii ju awọn itọju bošewa nikan lọ.
  • Imudarasi ilana iṣoogun ti a pe ni itu ẹjẹ. Iwadi ni kutukutu fihan pe resveratrol le jẹ ki sisẹ ẹjẹ lọ yarayara ni awọn eniyan ti o ni itu ẹjẹ.
  • Ẹjẹ homonu ti o fa awọn ẹyin ti o gbooro pẹlu awọn cysts (polycystic ovary syndrome tabi PCOS). Iwadi ni kutukutu fihan pe resveratrol dinku testosterone ninu awọn obinrin pẹlu PCOS. Ṣugbọn kii ṣe ilọsiwaju iwuwo, awọn ipele ọra, irorẹ, tabi idagbasoke irun aifẹ ninu awọn obinrin ti o ni ipo yii.
  • Arthritis Rheumatoid (RA). Gbigba resveratrol pẹlu awọn oogun fun RA dabi pe o dinku nọmba ti awọn isẹpo ti o ni irora ati ti o wú. Ṣugbọn a ko mọ boya resveratrol tun ṣe iranlọwọ idinku ibajẹ apapọ.
  • Iru arun inu ifun ẹdun (ulcerative colitis). Iwadi ni kutukutu fihan resveratrol le mu awọn aami aisan dara ati dinku iṣẹ ti ọgbẹ ọgbẹ.
  • Awọ ti ogbo.
  • Kọ silẹ ni iranti ati awọn ọgbọn ero ninu awọn eniyan agbalagba ti o jẹ diẹ sii ju ohun ti o ṣe deede fun ọjọ-ori wọn.
  • Ikun ti awọn iṣọn ara (atherosclerosis).
  • Iranti ati awọn ọgbọn ero (iṣẹ imọ).
  • Awọn ipo miiran.
A nilo ẹri diẹ sii lati ṣe iwọn resveratrol fun awọn lilo wọnyi.

Resveratrol le faagun awọn ohun elo ẹjẹ ati dinku iṣẹ ti awọn sẹẹli pataki ninu didi ẹjẹ. Diẹ ninu iwadi ṣe imọran pe resveratrol ni awọn estrogen ti ko lagbara (homonu abo). O tun le dinku irora ati wiwu (igbona). Resveratrol le dinku awọn ipele suga (glucose) ninu ẹjẹ ati ṣe iranlọwọ fun ara lati ja lodi si arun. O tun le ṣe idiwọ awọn ọlọjẹ ninu ọpọlọ lati faramọ papọ lati ṣe iranlọwọ lati dena awọn aisan bii aisan Alzheimer.

Nigbati o ba ya nipasẹ ẹnu: Resveratrol jẹ O ṣee ṣe NI Ailewu nigba lilo ninu awọn oye ti a ri ninu awọn ounjẹ. Nigbati o ba ya ni awọn abere to 1500 mg lojoojumọ fun oṣu mẹta, resveratrol jẹ Ailewu Ailewu. Awọn abere to ga julọ ti o to 2000-3000 mg lojoojumọ ti lo lailewu fun awọn oṣu 2-6. Sibẹsibẹ, awọn iwọn lilo giga ti resveratrol ni o seese ki o fa awọn iṣoro ikun.

Nigbati a ba loo si awọ ara: Resveratrol jẹ Ailewu Ailewu nigba lilo si awọ ara fun ọjọ ọgbọn.

Awọn iṣọra pataki & awọn ikilo:

Oyun ati fifun-igbaya: Resveratrol jẹ O ṣee ṣe NI Ailewu nigba lilo ni awọn oye ti a rii ni diẹ ninu awọn ounjẹ. Sibẹsibẹ, lakoko oyun ati fifun-igbaya, orisun ti resveratrol jẹ pataki. A rii Resveratrol ni awọn awọ-ajara, oje eso ajara, ọti-waini, ati awọn orisun ounjẹ miiran. Ko yẹ ki a lo ọti-waini bi orisun ti resveratrol lakoko oyun ati fifun-igbaya.

Awọn ọmọde: Resveratrol jẹ Ailewu Ailewu ninu awọn ọmọde nigbati wọn ba fun wọn ni iho imu fun oṣu meji.

Awọn rudurudu ẹjẹ: Resveratrol le fa fifalẹ didi ẹjẹ ati mu eewu ẹjẹ silẹ ni awọn eniyan ti o ni awọn rudurudu ẹjẹ.

Ipo ti o nira fun Hormone bii aarun igbaya, aarun ti ile-ọmọ, akàn ọjẹ, endometriosis, tabi fibroids uterine: Resveratrol le ṣe bi estrogen. Ti o ba ni ipo eyikeyi ti o le jẹ ki o buru sii nipasẹ ifihan si estrogen, maṣe lo resveratrol.

Isẹ abẹ: Resveratrol le mu eewu ẹjẹ pọ si lakoko ati lẹhin iṣẹ abẹ. Da lilo resveratrol o kere ju ọsẹ 2 ṣaaju iṣẹ abẹ ti a ṣeto.

Dede
Ṣọra pẹlu apapo yii.
Awọn oogun ti yipada nipasẹ ẹdọ (Cytochrome P450 1A1 (CYP1A1) awọn iyọti)
Diẹ ninu awọn oogun ti wa ni iyipada ati fifọ nipasẹ ẹdọ. Resveratrol le dinku bawo ni ẹdọ ṣe fọ diẹ ninu awọn oogun. Ni imọran, gbigba resveratrol pẹlu diẹ ninu awọn oogun ti o fọ nipasẹ ẹdọ le mu awọn ipa ati awọn ipa ẹgbẹ diẹ ninu awọn oogun pọ si.

Diẹ ninu awọn oogun ti o yipada nipasẹ ẹdọ pẹlu chlorzoxazone, theophylline, ati bufuralol.
Awọn oogun ti yipada nipasẹ ẹdọ (Cytochrome P450 1A2 (CYP1A2) sobusitireti)
Diẹ ninu awọn oogun ti wa ni iyipada ati fifọ nipasẹ ẹdọ. Resveratrol le dinku bawo ni ẹdọ ṣe fọ diẹ ninu awọn oogun. Ni imọran, gbigba resveratrol pẹlu diẹ ninu awọn oogun ti o fọ nipasẹ ẹdọ le mu awọn ipa ati awọn ipa ẹgbẹ diẹ ninu awọn oogun pọ si.

Diẹ ninu awọn oogun ti a yipada nipasẹ ẹdọ pẹlu clozapine (Clozaril), cyclobenzaprine (Flexeril), fluvoxamine (Luvox), haloperidol (Haldol), imipramine (Tofranil), mexiletine (Mexitil), olanzapine (Zyprexa), pentazocine (Talwin) prop ), tacrine (Cognex), zileuton (Zyflo), zolmitriptan (Zomig), ati awọn omiiran.
Awọn oogun yipada nipasẹ ẹdọ (Cytochrome P450 1B1 (CYP1B1) sobusitireti)
Diẹ ninu awọn oogun ti wa ni iyipada ati fifọ nipasẹ ẹdọ. Resveratrol le dinku bawo ni ẹdọ ṣe fọ diẹ ninu awọn oogun. Ni imọran, gbigba resveratrol pẹlu diẹ ninu awọn oogun ti o fọ nipasẹ ẹdọ le mu awọn ipa ati awọn ipa ẹgbẹ diẹ ninu awọn oogun pọ si.

Diẹ ninu awọn oogun ti o yipada nipasẹ ẹdọ pẹlu theophylline, omeprazole, clozapine, progesterone, lansoprazole, flutamide, oxaliplatin, erlotinib, ati caffeine.
Awọn oogun ti a yipada nipasẹ ẹdọ (Cytochrome P450 2C19 (CYP2C19) sobusitireti)
Diẹ ninu awọn oogun ti wa ni iyipada ati fifọ nipasẹ ẹdọ. Resveratrol le dinku bawo ni ẹdọ ṣe fọ diẹ ninu awọn oogun. Ni imọran, gbigba resveratrol pẹlu diẹ ninu awọn oogun ti o fọ nipasẹ ẹdọ le mu awọn ipa ati awọn ipa ẹgbẹ diẹ ninu awọn oogun pọ si.

Diẹ ninu awọn oogun ti o yipada nipasẹ ẹdọ pẹlu amitriptyline (Elavil), carisoprodol (Soma), citalopram (Celexa), diazepam (Valium), lansoprazole (Prevacid), omeprazole (Prilosec), phenytoin (Dilantin), warfarin, ati ọpọlọpọ awọn miiran.
Awọn oogun yipada nipasẹ ẹdọ (Cytochrome P450 2E1 (CYP2E1) awọn iyọti)
Diẹ ninu awọn oogun ti wa ni iyipada ati fifọ nipasẹ ẹdọ. Resveratrol le dinku bawo ni ẹdọ ṣe fọ diẹ ninu awọn oogun. Ni imọran, gbigba resveratrol pẹlu diẹ ninu awọn oogun ti o fọ nipasẹ ẹdọ le mu awọn ipa ati awọn ipa ẹgbẹ diẹ ninu awọn oogun pọ si.

Diẹ ninu awọn oogun ti a yipada nipasẹ ẹdọ pẹlu acetaminophen, chlorzoxazone (Parafon Forte), ethanol, theophylline, ati awọn anesthetics bii enflurane (Ethrane), halothane (Fluothane), isoflurane (Forane), methoxyflurane (Penthrane).
Awọn oogun yipada nipasẹ ẹdọ (Cytochrome P450 3A4 (CYP3A4) sobusitireti)
Diẹ ninu awọn oogun ti wa ni iyipada ati fifọ nipasẹ ẹdọ. Resveratrol le dinku bawo ni ẹdọ ṣe fọ diẹ ninu awọn oogun. Ni imọran, gbigba resveratrol pẹlu diẹ ninu awọn oogun ti o fọ nipasẹ ẹdọ le mu awọn ipa ati awọn ipa ẹgbẹ diẹ ninu awọn oogun pọ si. Sibẹsibẹ, diẹ ninu iwadi akọkọ fihan awọn esi ti o fi ori gbarawọn.

Diẹ ninu awọn oogun ti o yipada nipasẹ ẹdọ pẹlu diẹ ninu awọn oluṣọnwọle ikanni kalisia (diltiazem, nicardipine, verapamil), awọn aṣoju chemotherapeut (etoposide, paclitaxel, vinblastine, vincristine, vindesine), antifungals (ketoconazole, itraconazole), glucocorticoids, alfentanil (Alfenta) ), fentanyl (Sublimaze), lidocaine (Xylocaine), losartan (Cozaar), fexofenadine (Allegra), midazolam (Ẹsẹ), ati awọn miiran.
Awọn oogun ti o fa fifalẹ didi ẹjẹ (Anticoagulant / Antiplatelet drugs)
Resveratrol le fa fifalẹ didi ẹjẹ. Gbigba resveratrol pẹlu awọn oogun ti o tun fa fifalẹ didi le mu awọn aye ti ọgbẹ ati ẹjẹ pọ si.

Diẹ ninu awọn oogun ti o fa fifalẹ didi ẹjẹ pẹlu aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, awọn miiran), ibuprofen (Advil, Motrin, awọn miiran), naproxen (Anaprox, Naprosyn, awọn miiran), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), ati awọn omiiran.
Ewebe ati awọn afikun ti o le fa fifalẹ didi ẹjẹ (Anticoagulant / Antiplatelet herbs and supplements)
Resveratrol le fa fifalẹ didi ẹjẹ. Lilo rẹ pẹlu awọn ewe miiran tabi awọn afikun ti o le tun fa fifalẹ didi ẹjẹ le mu ki eewu ẹjẹ tabi ọgbẹ pọ si diẹ ninu awọn eniyan. Awọn ewe wọnyi pẹlu angelica, clove, danshen, feverfew, ata ilẹ, Atalẹ, ginkgo, ginseng Panax, chestnut ẹṣin, clover pupa, turmeric, ati awọn omiiran.
Awọn ọra ati awọn ounjẹ ti o ni ọra ninu
Gbigba resveratrol pẹlu ounjẹ ti o ga ninu ọra le dinku iye resveratrol ti o gba nipasẹ ara.
Awọn abere wọnyi ni a ti kẹkọọ ninu iwadi ijinle sayensi:

AWON AGBA

NIPA ẹnu:
  • Fun awọn nkan ti ara korira ti igba (iba iba): Awọn sokiri meji ti sokiri imu ti 0.1% resveratrol sinu imu kọọkan ni igba mẹta / ọjọ fun ọsẹ mẹrin 4.
  • Fun isanraju: 500 miligiramu tabi kere si ti resveratrol lojoojumọ fun osu mẹta tabi gun.
3,5,4 'TriHydroxy-Transstibene, (E) - 5- (4-hydroxystyryl) benzene-1,3-diol, 3,4', 5-stilbenetriol, 3,5,4 '-trihydroxystilbene, 3,4 ', 5-trihydroxystilbene, 3,5,4'-trihydroxy-trans-stilbene, Cis-Resveratrol, Extrait de Vin, Extrait de Vin Rouge, Kojo-Kon, Phytoalexin, Phytoalexine, Phytoestrogen, Phyto-œstrogène, Pilule de Vin, Protykin, Omi Waini pupa, Resvératrol, Resveratrols, Resvératrols, RSV, RSVL, Stilbene Phytoalexin, Trans-Resveratrol, Trans-Resvératrol, Waini Waini, Waini Waini.

Lati kọ diẹ sii nipa bi a ṣe kọ nkan yii, jọwọ wo Awọn Ile-ẹkọ Iṣeduro Alaye Awọn Oogun Adayeba ilana.


  1. Zhang N, Liang T, Jin Q, Shen C, Zhang Y, Jing P. Iṣu Ṣaina (Dioscorea opposita Thunb.) Mu igbẹ gbuuru ti o ni nkan aporo pọ si, ṣe atunṣe microbiota ti inu, ati mu alekun ipele awọn acids fatty kukuru pọ ninu awọn eku. Ounjẹ Res Int. 2019; 122: 191-198. Wo áljẹbrà.
  2. Akbari M, Tamtaji OR, Lankarani KB, et al. Awọn ipa ti ifikun resveratrol lori iṣẹ endothelial ati awọn igara ẹjẹ laarin awọn alaisan pẹlu iṣọn-ara ti iṣelọpọ ati awọn rudurudu ti o jọmọ: atunyẹwo eto-ẹrọ ati igbekale apẹẹrẹ ti awọn iwadii ti a sọtọ. Ẹjẹ Titẹ Ẹjẹ Cardiovasc Prev 2019; 26: 305-19. Wo áljẹbrà.
  3. Köbe T, Witte AV, Schnelle A, et al. Ipa ti resveratrol lori iṣakoso glucose, iṣeto hippocampal ati sisopọ, ati iṣẹ iranti ni awọn alaisan ti o ni aibawọn imọ aitọ. Neurosci iwaju 2017; 11: 105. Wo áljẹbrà.
  4. Witte AV, Kerti L, Margulies DS, Flöel A. Awọn ipa ti resveratrol lori iṣẹ iranti, asopọ iṣẹ hippocampal, ati iṣelọpọ glucose ni awọn agbalagba ti o ni ilera. J Neurosci 2014; 34: 7862-70. Wo áljẹbrà.
  5. Mousavi SM, Milajerdi A, Sheikhi A, et al. Atunṣe Resveratrol ṣe pataki ni ipa awọn igbese isanraju: atunyẹwo eto-ẹrọ ati igbekale iwọn-adaṣe onínọmbà ti awọn iwadii iṣakoso ti a sọtọ. Obes Rev 2019; 20: 487-98. Wo áljẹbrà.
  6. Sattarinezhad A, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M. Resveratrol dinku albuminuria ni nephropathy ti ọgbẹ: aarun idanimọ ibi-iṣakoso afọju afọju meji. Diabetes Metab 2019; 45: 53-9. Wo áljẹbrà.
  7. Zhang C, Yuan W, Fang J, Wang W, He P, Lei J, Wang C. Imudarasi ti Afikun Resveratrol lodi si Arun Ẹdọ ti kii-Ọti-Ọti: Ayẹwo Meta-ti Awọn idanwo Iṣoogun ti Iṣakoso. PLoS Ọkan. 2016 Oṣu Kẹjọ 25; 11: e0161792. Wo áljẹbrà.
  8. Poulsen MK, Nellemann B, Bibby BM, et al. Ko si ipa ti resveratrol lori awọn kinetikisi VLDL-TG ati ifamọ insulin ni awọn ọkunrin ti o sanra pẹlu arun ẹdọ ọra ti ko ni ọti-lile. Diabetes Obes Metab. 2018; 20: 2504-2509. Wo áljẹbrà.
  9. Hussain SA, Marouf BH, Ali ZS, Ahmmad RS. Agbara ati ailewu ti ifowosowopo ti resveratrol pẹlu meloxicam ni awọn alaisan ti o ni osteoarthritis orokun: iwadii ilowosi awakọ kan. Ile-iwosan Interv Aging. 2018; 13: 1621-1630. Wo áljẹbrà.
  10. Huhn S, Beyer F, Zhang R, et al. Awọn ipa ti resveratrol lori iṣẹ iranti, isopọmọ hippocampus ati microstructure ni awọn agbalagba - Iwadii iṣakoso ti a sọtọ. Neuroimage. 2018; 174: 177-190. Wo áljẹbrà.
  11. Haghpanah S, Zarei T, Eshghi P, et al. Agbara ati ailewu ti resveratrol, roba hemoglobin F-augmenting oluranlowo, ninu awọn alaisan pẹlu beta-thalassemia intermedia. Ann Hematol. 2018; 97: 1919-1924. Wo áljẹbrà.
  12. Anton SD, Ebner N, Dzierzewski JM, et al. Awọn ipa ti Awọn ọjọ 90 ti Ifikun Resveratrol lori Iṣẹ Imọ ni Awọn Alàgba: Iwadi Pilot kan. J Yiyan Afikun Med. 2018; 24: 725-732. Wo awọn afoyemọ.
  13. Lv C, Zhang Y, Shen L. Imudara ipa iṣaaju iwosan ti resveratrol ninu awọn agbalagba pẹlu rhinitis inira. Imunolu Allergy Int Arch 2018; 175: 231-6. Wo áljẹbrà.
  14. Zortea K, Franco VC, Francesconi LP, Cereser KM, Lobato MI, Belmonte-de-Abreu PS. Atunṣe Resveratrol ni Awọn Alaisan Schizophrenia: Iwadii Iwadii Iṣoogun Ti a Ṣayanju Ṣiṣayẹwo Glucose Omi-ara ati Awọn Okunfa Ewu eegun. Awọn ounjẹ. 2016; 8: 73. Wo áljẹbrà.
  15. Wightman EL, Haskell-Ramsay CF, Reay JL, et al. Awọn ipa ti afikun trans-resveratrol afikun lori awọn aaye ti iṣẹ iṣaro, iṣesi, oorun, ilera ati iṣan ẹjẹ ọpọlọ ni ilera, awọn ọdọ. Br J Nutr. 2015; 114: 1427-37. Wo áljẹbrà.
  16. Turner RS, Thomas RG, Iṣẹ ọwọ S, et al. Aṣoju, afọju meji, idanwo iṣakoso ibibo ti resveratrol fun arun Alzheimer. Neurology. 2015; 85: 1383-91. Wo áljẹbrà.
  17. Timmers S, de Ligt M, Phielix E, et al. Resveratrol bi Itọju-Afikun-ni Awọn Koko-ọrọ Pẹlu Iru 2 Diabetes Iṣakoso Tọju-Daradara: Iwadii Iṣakoso Aileto kan. Itọju Àtọgbẹ. 2016; 39: 2211-2217. Wo áljẹbrà.
  18. Samsami-Kor M, Daryani NE, Asl PR, Hekmatdoost A. Awọn ipa alatako-iredodo ti Resveratrol ni Awọn alaisan ti o ni Ọgbẹ Ọdun: Aṣayanju kan, Onidọ meji-meji, Iwadi Pilot ti iṣakoso. Aaki Med Res. 2015; 46: 280-5. Wo áljẹbrà.
  19. Lin CT, Sun XY, Lin AX. Afikun pẹlu iwọn-giga trans-resveratrol ṣe ilọsiwaju ultrafiltration ni awọn alaisan itu ẹjẹ peritoneal: ifojusọna, ti a sọtọ, iwadi afọju meji. Ren kuna. 2016; 38: 214-21. Wo áljẹbrà.
  20. Kjaer TN, Ornstrup MJ, Poulsen MM, et al. Resveratrol dinku awọn ipele ti ṣiṣere androgen precursors ṣugbọn ko ni ipa lori, testosterone, dihydrotestosterone, awọn ipele PSA tabi iwọn itọ-itọ. Iwadii ti a sọtọ ti oṣu mẹrin 4 ni awọn ọkunrin agbalagba. Itọ-itọ. 2015; 75: 1255-63. Wo áljẹbrà.
  21. Evans HM, Howe PR, Wong RH. Awọn ipa ti Resveratrol lori Iṣe Imọ, Iṣesi ati Iṣe Cerebrovascular ni Awọn Obirin Lẹhin-Menopausal; Iwadii Idojukọ Ibi Iṣakoso Iṣakoso ti Iṣakoso-Iṣakoso ID-Ọsẹ 14. Awọn ounjẹ. 2017; Wo áljẹbrà.
  22. Elgebaly A, Radwan IA, AboElnas MM, et al. Atunṣe Resveratrol ni Awọn alaisan pẹlu Arun Ẹdọ ti kii-Ọti-Ọra: Atunyẹwo Eto-ara ati igbekale Meta. J Gastrointestin Ẹdọ Dis. 2017; 26: 59-67.Wo áljẹbrà.
  23. Bo S, Ponzo V, Ciccone G, ati al. Oṣu mẹfa ti afikun afikun resveratrol ko ni ipa wiwọn ni iru awọn alaisan ọgbẹ 2 iru. Aṣoju, afọju meji, iwadii iṣakoso ibibo. Ile-iṣẹ Pharmacol. 2016; 111: 896-905. Wo áljẹbrà.
  24. Bedada SK, Neerati P. Resveratrol Pretreatment Yoo kan CYP2E1 Iṣẹ ti Chlorzoxazone ni Awọn oluyọọda Eniyan ilera. Phytother Res. 2016; 30: 463-8. Wo áljẹbrà.
  25. Banaszewska B, Wrotynska-Barczynska J, Spaczynski RZ, Pawelczyk L, Duleba AJ. Awọn ipa ti Resveratrol lori Aarun Ẹjẹ Polycystic: Aju afọju meji, Aileto, Iwadii iṣakoso Ibibo. J Clin Endocrinol Metab. 2016; 101: 4322-4328. Wo áljẹbrà.
  26. Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Resveratrol gegebi itọju arannilọwọ ti o munadoko ninu iṣakoso ti arthritis rheumatoid: iwadii ile-iwosan kan. Iwosan Rheumatol. 2018; [Epub niwaju titẹ]. Wo áljẹbrà.
  27. Shishodia S, Aggarwal BB. Resveratrol: polyphenol kan fun gbogbo awọn akoko. Resveratrol ni ilera ati arun. Boca Raton, FL: CRC Tẹ, 2005.
  28. Creasy LL, Kofi M. Phytoalexin agbara iṣelọpọ ti awọn eso ajara. J Am Soc Hortic Sci. 1988; 113: 230-234.
  29. Langcake P, McCarthy W. Ibasepo iṣelọpọ ti resveratrol si ikolu ti awọn eso ajara nipasẹ Botrytis cinerea. Ọgbẹ. 1979; 18: 244-253.
  30. Iye owo NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA. SIRT1 nilo fun ṣiṣiṣẹ AMPK ati awọn ipa anfani ti resveratrol lori iṣẹ mitochondrial. Sẹẹli Metab. 2012 May 2; 15: 675-90. Wo áljẹbrà.
  31. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL. Awọn imọran aramada ti awọn polyphenols ti ounjẹ ati isanraju. J Nutr Biochem. Ọdun 2014; 25: 1-18. Wo áljẹbrà.
  32. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E. Idinamọ ti aarun ayọkẹlẹ Aṣẹ atunse ọlọjẹ nipasẹ resveratrol. J Aisan Dis. 2005 May 15; 191: 1719-29. Wo áljẹbrà.
  33. Mastromarino P, Capobianco D, Cannata F, Nardis C, Mattia E, De Leo A, Restignoli R, Francioso A, Mosca L. Resveratrol ṣe idiwọ atunṣe rhinovirus ati ikosile ti awọn olulaja iredodo ni epithelia ti imu. Antiviral Res. Oṣu kọkanla 2015; 123: 15-21. Wo áljẹbrà.
  34. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Majele kidirin ti o ni nkan ṣe pẹlu Resveratrol. Toxicol Sci. Oṣu kejila 2004; 82: 614-9. Wo áljẹbrà.
  35. Semba RD, Ferrucci L, Bartali B, Urpí-Sarda M, Zamora-Ros R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C. Awọn ipele Resveratrol ati gbogbo-fa iku ni awọn agbalagba agbalagba olugbe agbegbe. JAMA Akọṣẹ Med. Oṣu Kẹwa 2014; 174: 1077-84. Wo áljẹbrà.
  36. Sahebkar A. Awọn ipa ti ifikun resveratrol lori awọn ọta pilasima: atunyẹwo eto-ẹrọ ati igbekale meta ti awọn idanwo idanimọ alaimọ. Nutr Rev. 2013 Oṣu kejila; 71: 822-35. Wo áljẹbrà.
  37. Miraglia Del Giudice M, Maiello N, Capristo C, Alterio E, Capasso M, Perrone L, Ciprandi G. Resveratrol plus carboxymethyl-ß-glucan dinku awọn aami aiṣan ti imu ni awọn ọmọde pẹlu rhinitis inira ti o ni eruku adodo. Curr Med Res Opin. Oṣu Kẹwa 2014; 30: 1931-5. Wo áljẹbrà.
  38. Méndez-del Villar M, González-Ortiz M, Martínez-Abundis E, Pérez-Rubio KG, Lizárraga-Valdez R. Ipa ti iṣakoso resveratrol lori iṣọn-ara ti iṣelọpọ, ifamọ insulin, ati ifasilẹ insulin. Metab Syndr Relat Ẹjẹ. 2014 Oṣu kejila; 12: 497-501. Wo áljẹbrà.
  39. Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E. Cardioprotection nipasẹ resveratrol: Iwadii iwosan ti eniyan ni awọn alaisan pẹlu iṣọn-alọ ọkan iṣọn-alọ ọkan. Ile-iwosan Hemorheol Microcirc. 2012; 50: 179-87. Wo áljẹbrà.
  40. Liu K, Zhou R, Wang B, Mi MT. Ipa ti resveratrol lori iṣakoso glukosi ati ifamọ insulin: igbekale meta ti awọn idanwo idanimọ ti a sọtọ 11. Am J Clin Nutr. Ọdun 2014; 99: 1510-9. Wo áljẹbrà.
  41. Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Imudarasi Resveratrol ṣe imudarasi awọn oniṣowo biomarkers iredodo ni awọn alaisan pẹlu arun ẹdọ ọra ti kii ṣe ọti-lile. Nutr Res. Oṣu Kẹwa 2014; 34: 837-43. Wo áljẹbrà.
  42. Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CM, Prins JB, Hickman IJ. Resveratrol ko ni anfani awọn alaisan pẹlu arun ẹdọ ọra ti kii ṣe ọti-lile. Iwosan Gastroenterol Hepatol. Oṣu kejila 2014; 12: 2092-103.e1-6. Wo áljẹbrà.
  43. Hudson, GM, Shelmadine, B., Cooke, M., Genovese, J., Greenwood, M., ati Willoughby, Imikun DS Resveratrol Ati Awọn ayipada Ninu Glucose, Insulin, Ati Ifarahan mRNA Atẹle Idaraya Ni Awọn Obirin Iwọnju: 2467. Oogun & Imọ ni Awọn idaraya & adaṣe 2011; 43
  44. Guarnieri, R., Pappacoda, A., ati Solitro, S. [A resveratrol ti o ni akopọ dinku aapọn aapọn ati mu awọn aami aiṣan ti iwosan dara ni awọn akọle COPD] Un composto a base di resveratrolo riduce lo stress ossidativo e migliora la sintomatologia clinica in soggetti con BPCO . Cochrane Central Forukọsilẹ ti Awọn idanwo Iṣakoso 2009;
  45. Yoon, SJ, Cho, KS, Lee, YH, Kim, DS, ati Hong, SJ RESVERATROL INHIBITS CXCR4 IDAGBASOKE TUMOR ATI Iṣipopada CELL CIDNEY KIDNEY CELL IN VITRO AND IN VIVO: 428. Iwe akosile ti Urology 2009; 181: 153- 154.
  46. Klink, JC, Poulton, S., Antonelli, J., Potter, MQ, Jayachandran, J., Tewari, AK, Febbo, PG, Pizzo, SV ati Freedland ti Urology 2009; 181
  47. Seely, K. A. Cannabinoid olugba oniduro agonists bi awọn aṣoju itọju aramada. "Awọn imọ-jinlẹ ati Imọ-iṣe. Awọn imọ-jinlẹ ati Imọ-iṣe 2009; 70 (4-B)
  48. Pregliasco, F. ati Cogo, R. [Antioxidant ati awọn agbo ogun ajesara ni awọn eniyan agbalagba ti o ngba ajesara aarun ayọkẹlẹ ti igba mu ilọsiwaju esi serological ati dinku awọn iṣẹlẹ atẹgun atẹgun] L’uso di sostanze antiossidanti ed immunomodulanti in una popolazione anziana so. Cochrane Central Forukọsilẹ ti Awọn idanwo Iṣakoso 2010;
  49. Steigerwald, M. D., Fisk, M. Z., Smoliga, J. M., ati Rundell, K. W. Awọn ipa ti Resveratrol Lori Wahala atẹgun Ati Ipa ti iṣan Lẹhin Idaraya Ni Imukuro Afẹfẹ Afẹfẹ: 2645. Oogun & Imọ ni Awọn idaraya & Idaraya 2011; 43
  50. Bost, J., Smoliga, JM, Bost, KM, ati Maroon, JC Awọn oṣooṣu Oral Afikun Afikun Polyphenol Alailẹgbẹ Awọn ilọsiwaju Awọn iṣe iṣe ti ara ati Neurocognitive ni Awọn agbalagba Sedentary: 2205. Oogun & Imọ ni Awọn idaraya & Idaraya 2008; 40: S246 .
  51. Grujic Milanovic, J., Mihailovic-Stanojevic, N., Miloradovic, Z., Jacevic, V., Milosavljevic, I., Milanovic, S., Ivanov, M., ati Jovovic, DJ RESVERATROL dinku awọn titẹ ẹjẹ, Awọn iyipada ti ANTIOXIDANT ISE ENZYME ATI AWỌN OHUN TI ẸRỌ NIPA NIPA IWỌN NIPA TI ẸMỌ TI OHUN TI PP.29.171. Iwe akosile ti Haipatensonu 2010; 28
  52. Pendurthi, U. R., Williams, J. T., ati Rao, L. V. Resveratrol, apopọ polyphenolic ti o wa ninu ọti-waini, dena ikasi ifosiwewe ti ara ni awọn sẹẹli iṣan: Ẹrọ ti o ṣeeṣe fun awọn anfani inu ọkan ati ẹjẹ ti o ni ibatan pẹlu agbara mimu ti ọti-waini. Arterioscler.Thromb.Vasc.Biol 1999; 19: 419-426. Wo áljẹbrà.
  53. Rotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotillo, D., de Gaetano, G., Evangelista, V., ati Cerletti, C. Ipa ti trans-resveratrol, polyphenolic ti ara apapọ, lori iṣẹ leukocyte polymorphonuclear eniyan. Br.J. Pharmacol. 1998; 123: 1691-1699. Wo áljẹbrà.
  54. Bhatt, J. K., Thomas, S., ati Nanjan, M. J. Resveratrol imudara imudarasi iṣakoso glycemic ni iru 2 diabetes mellitus. Nutr.Res. 2012; 32: 537-541. Wo áljẹbrà.
  55. Hector, K. L., Lagisz, M., ati Nakagawa, S. Ipa ti resveratrol lori gigun lori gbogbo eeya: igbekale meta. Biol Jẹ ki. 10-23-2012; 8: 790-793. Wo áljẹbrà.
  56. Roehr, B. Oluwadi nipa iṣọn-ẹjẹ ṣe awọn data ni awọn ẹkọ ti ọti-waini pupa. BMJ 2012; 344: e406. Wo áljẹbrà.
  57. Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., ati Barzilai, N. Pilot iwadi ti resveratrol ni awọn agbalagba agbalagba pẹlu ifarada glucose to bajẹ. J.Gerontol.A Biol.Sci.Med.Sci. 2012; 67: 1307-1312. Wo áljẹbrà.
  58. Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., Iwasaka, T., ati Das, DK Ti a ṣe atunṣe resveratrol Longevinex ṣe ilọsiwaju iṣẹ endothelial ninu awọn agbalagba ti o ni ailera ti iṣelọpọ ti ngba itọju deede. Nutr.Res 2011; 31: 842-847. Wo áljẹbrà.
  59. Timmers, S., Konings, E., Bilet, L., Houtkooper, RH, van de Weijer, T., Goossens, GH, Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S ., Moonen-Kornips, E., Hesselink, MK, Kunz, I., Schrauwen-Hinderling, VB, Blaak, EE, Auwerx, J., ati Schrauwen, P. Calorie ihamọ-bi awọn ipa ti awọn ọjọ 30 ti afikun resveratrol lori iṣelọpọ agbara ati profaili ti iṣelọpọ ni awọn eniyan ti o sanra. Ẹrọ Metab 11-2-2011; 14: 612-622. Wo áljẹbrà.
  60. Xuzhu, G., Komai-Koma, M., Leung, B. P., Howe, H. S., McSharry, C., McInnes, I. B., ati Xu, D. Resveratrol ṣe atunṣe apẹrẹ ti kolaginni ti kolari murine nipasẹ didena iṣẹ Th17 ati B-cell. Ann. Rehemu.Dis 2012; 71: 129-135. Wo áljẹbrà.
  61. Knight, CM, Gutierrez-Juarez, R., Lam, TK, Arrieta-Cruz, I., Huang, L., Schwartz, G., Barzilai, N., ati Rossetti, L. Mediobasal hypothalamic SIRT1 jẹ pataki fun awọn ipa ti resveratrol lori iṣẹ insulini ninu awọn eku. Àtọgbẹ 2011; 60: 2691-2700. Wo áljẹbrà.
  62. Howells, LM, Berry, DP, Elliott, PJ, Jacobson, EW, Hoffmann, E., Hegarty, B., Brown, K., Steward, WP, ati Gescher, AJ Alakoso I ti sọtọ, iwadi awakọ afọju meji ti micronized resveratrol (SRT501) ni awọn alaisan ti o ni awọn metastases ẹdọ - aabo, oogun-oogun, ati oogun-oogun. Akàn Prev.Res (Phila) 2011; 4: 1419-1425. Wo áljẹbrà.
  63. Wuertz, K., Quero, L., Sekiguchi, M., Klawitter, M., Nerlich, A., Konno, S., Kikuchi, S., ati Boos, N. Ọti-waini pupa polyphenol resveratrol fihan agbara ileri fun itọju ti irora pulposus-mediated irora in vitro ati ni vivo. Ẹtan (Phila Pa 1976.) 10-1-2011; 36: E1373-E1384. Wo áljẹbrà.
  64. Brasnyo, P., Molnar, GA, Mohas, M., Marko, L., Laczy, B., Cseh, J., Mikolas, E., Szijarto, IA, Merei, A., Halmai, R., Meszaros, LG, Sumegi, B., ati Wittmann, I. Resveratrol ṣe ilọsiwaju ifamọ insulin, dinku aapọn atẹgun ati mu ọna Akt ṣiṣẹ ni iru awọn alaisan ọgbẹ 2 iru. Br J Nutr. 2011; 106: 383-389. Wo áljẹbrà.
  65. Fabbrocini, G., Staibano, S., De, Rosa G., Battimiello, V., Fardella, N., Ilardi, G., La Rotonda, MI, Longobardi, A., Mazzella, M., Siano, M. , Pastore, F., De, Vita, V, Vecchione, ML, ati Ayala, F. Resveratrol ti o ni gel fun itọju irorẹ irorun: afọju kan, ti iṣakoso ọkọ, iwadi awakọ. Am J Clin.Dermatol 4-1-2011; 12: 133-141. Wo áljẹbrà.
  66. Kitada, M., Kume, S., Imaizumi, N., ati Koya, D. Resveratrol ṣe imudara aapọn ati ki o daabobo lodi si nephropathy ti ọgbẹ nipasẹ iwuwasi ti aiṣedede Mn-SOD ni ọna AMPK / SIRT1. Àtọgbẹ 2011; 60: 634-643. Wo áljẹbrà.
  67. Shindler, K. S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D. C., ati Rostami, A. Ove resveratrol dinku ibajẹ iṣan ni awoṣe ti ọpọlọ-ọpọlọ pupọ. J Neuroophthalmol. 2010; 30: 328-339. Wo áljẹbrà.
  68. Brown, VA, Patel, KR, Viskaduraki, M., Crowell, JA, Perloff, M., Booth, TD, Vasilinin, G., Sen, A., Schinas, AM, Piccirilli, G., Brown, K., Iriju, WP, Gescher, AJ, ati Brenner, DE Tun iwadi iwọn lilo ti akàn chemopreventive agent resveratrol ninu awọn oluyọọda ilera: ailewu, oogun-oogun, ati ipa lori ipo ifosiwewe idagbasoke iru-insulin. Akàn Res 11-15-2010; 70: 9003-9011. Wo áljẹbrà.
  69. Patel, KR, Brown, VA, Jones, DJ, Britton, RG, Hemingway, D., Miller, AS, West, KP, Booth, TD, Perloff, M., Crowell, JA, Brenner, DE, Steward, WP, Gescher, AJ, ati Brown, K. Iṣoogun ti ile-iwosan ti resveratrol ati awọn iṣelọpọ rẹ ni awọn alaisan akàn awọ. Akàn Res 10-1-2010; 70: 7392-7399. Wo áljẹbrà.
  70. Knobloch, J., Sibbing, B., Jungck, D., Lin, Y., Urban, K., Stoelben, E., Strauch, J., ati Koch, A. Resveratrol ṣe idibajẹ ifasilẹ awọn cytokines iredodo sitẹriọdu lati atẹgun atẹgun ti dan eniyan awọn iṣan iṣan ni arun ẹdọforo idiwọ. J Pharmacol. Oṣu Kẹta. 2010; 335: 788-798. Wo áljẹbrà.
  71. Chow, HH, Garland, LL, Hsu, CH, Vining, DR, Chew, WM, Miller, JA, Perloff, M., Crowell, JA, ati Alberts, DS Resveratrol ṣe atunṣe oogun- ati awọn enzymu ti n ṣatunṣe eero-ara ni oluyọọda ilera kan iwadi. Akàn Prev.Res (Phila) 2010; 3: 1168-1175. Wo áljẹbrà.
  72. Wong, R. H., Howe, P. R., Buckley, J. D., Coates, A. M., Kunz, I., ati Berry, N. M. Imudara afikun resveratrol mu ilọsiwaju dilatation dilatation ni iwọn apọju iwọn / awọn ẹni-kọọkan pẹlu titẹ ẹjẹ ti o ga pẹlẹ. Nutr.Metab Cardiovasc.Dis 2011; 21: 851-856. Wo áljẹbrà.
  73. la, Porte C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., ati Cameron, DW Steady-State pharmacokinetics ati ifarada ti trans-resveratrol 2000 mg lemeji ojoojumo pẹlu ounjẹ, quercetin ati oti (ethanol) ninu awọn akọle eniyan ti ilera. Iwosan.Pacacokinet. 2010; 49: 449-454. Wo áljẹbrà.
  74. Le Couteur, D. G. ati Sinclair, D. A. Ilana alaworan kan fun idagbasoke awọn ọna itọju ti o mu alekun ilera wa ati idaduro iku. J Gerontol.A Biol.Sci.Med Sci. 2010; 65: 693-694. Wo áljẹbrà.
  75. Kennedy, DO, Wightman, EL, Reay, JL, Lietz, G., Okello, EJ, Wilde, A., ati Haskell, CF Awọn ipa ti resveratrol lori awọn oniṣan ẹjẹ iṣan ọpọlọ ati iṣẹ iṣaro ninu eniyan: afọju meji, pilasibo -akoso, iwadi adakoja. Am J Clin.Nutr. 2010; 91: 1590-1597. Wo áljẹbrà.
  76. Daffner, K. R. Igbega ti ogbo ọgbọn aṣeyọri: atunyẹwo gbogbogbo. J Alzheimers. Oṣuwọn 2010; 19: 1101-1122. Wo áljẹbrà.
  77. Yu, H. P., Hwang, T. L., Hwang, T. L., Yen, C. H., ati Lau, Y. T. Resveratrol ṣe idiwọ aiṣedede endothelial ati iṣelọpọ superoxide aortic lẹhin iṣọn-ẹjẹ ibajẹ nipasẹ ọna ọna hemeoxygenase-1 ti o gbẹkẹle estrogen. Itọju Crit Med 2010; 38: 1147-1154. Wo áljẹbrà.
  78. Albani, D., Polito, L., ati Forloni, G. Sirtuins bi awọn ibi-afẹde aramada fun arun Alzheimer ati awọn rudurudu neurodegenerative miiran: iwadii ati ẹri jiini. J Alzheimers. Oṣuwọn 2010; 19: 11-26. Wo áljẹbrà.
  79. Guo, J. P., Yu, S., ati McGeer, P. L. Simple in vitro awọn iwadii lati ṣe idanimọ awọn idiwọ apejọ amyloid-beta fun itọju ailera aisan Alzheimer. J Alzheimers. 2010; 19: 1359-1370. Wo áljẹbrà.
  80. Jha, R. K., Ma, Q., Sha, H., ati Palikhe, M. Ipa aabo ti resveratrol ni ipalara ọpọlọ ọgbẹ ti o nira pupọ. Pancreas 2009; 38: 947-953. Wo áljẹbrà.
  81. Zhang, H., Zhang, J., Ungvari, Z., ati Zhang, C. Resveratrol ṣe ilọsiwaju iṣẹ endothelial: ipa ti TNF {alpha} ati wahala atẹgun ti iṣan. Arterioscler.Thromb.Vasc.Biol. 2009; 29: 1164-1171. Wo áljẹbrà.
  82. Bournival, J., Quessy, P., ati Martinoli, M. G. Awọn ipa aabo ti resveratrol ati quercetin lodi si MPP + -iṣeduro idaamu atẹgun nipasẹ titọ awọn ami ti iku apoptotic ninu awọn ẹmu dopaminergic. Ẹyin Mol.Neurobiol. 2009; 29: 1169-1180. Wo áljẹbrà.
  83. Almeida, L., Vaz-da-Silva, M., Falcao, A., Soares, E., Costa, R., Loureiro, AI, Fernandes-Lopes, C., Rocha, JF, Nunes, T., Wright , L., ati Soares-da-Silva, P. Pharmacokinetic ati profaili aabo ti trans-resveratrol ni ikẹkọ iwọn lilo pupọ ni awọn oluyọọda ilera. Mol.Nutr.Food Res 2009; 53 Ipese 1: S7-15. Wo áljẹbrà.
  84. Vingtdeux, V., Dreses-Werringloer, U., Zhao, H., Davies, P., ati Marambaud, P. Agbara itọju ti resveratrol ni arun Alzheimer. BMC.Neurosci. 2008; 9 Ipese 2: S6. Wo áljẹbrà.
  85. Fan, E., Zhang, L., Jiang, S., ati Bai, Y. Awọn ipa anfani ti resveratrol lori atherosclerosis. J Ounjẹ Ounjẹ 2008; 11: 610-614. Wo áljẹbrà.
  86. Vaz-da-Silva, M., Loureiro, AI, Falcao, A., Nunes, T., Rocha, JF, Fernandes-Lopes, C., Soares, E., Wright, L., Almeida, L., ati Soares-da-Silva, P. Ipa ti ounjẹ lori profaili oogun ti trans-resveratrol. Int.J Clin. Pharmacol. Tẹhin 2008; 46: 564-570. Wo áljẹbrà.
  87. Dudley, J. I., Lekli, I., Mukherjee, S., Das, M., Bertelli, A. A., ati Das, D. K. Njẹ ọti-waini funfun ni o yẹ fun paradox Faranse? Ifiwera ti awọn ipa ti iṣọn-ẹjẹ ti awọn ẹmu pupa ati funfun ati awọn ẹgbẹ wọn: resveratrol, tyrosol, ati hydroxytyrosol. J Agric. Ounjẹ Chem. 10-22-2008; 56: 9362-9373. Wo áljẹbrà.
  88. Orallo, F. Trans-resveratrol: elixir idan kan ti ọdọ ayeraye? CurrMed Chem. 2008; 15: 1887-1898. Wo áljẹbrà.
  89. Rocha-Gonzalez, H. I., Ambriz-Tututi, M., ati Granados-Soto, V. Resveratrol: idapọpọ ti ara pẹlu agbara iṣoogun ninu awọn arun aarun iṣan. CNS Neurosci. Ni ọdun 2008; 14: 234-247. Wo áljẹbrà.
  90. Calabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, TE, Giuffrida Stella, AM, Schapira, T., Dinkova Kostova, AT, ati Rizzarelli, E. Idahun idaamu ti cellular: ibi-afẹde aramada kan fun imunilara ati itọju ajẹsara ti ara ni ogbologbo, awọn aiṣedede neurodegenerative ati gigun. Neurochem. 2008 2008; 33: 2444-2471. Wo áljẹbrà.
  91. Pearson, KJ, Baur, JA, Lewis, KN, Peshkin, L., Iye, NL, Labinskyy, N., Swindell, WR, Kamara, D., Iyatọ, RK, Perez, E., Jamieson, HA, Zhang, Y., Dunn, SR, Sharma, K., Pleshko, N., Woollett, LA, Csiszar, A., Ikeno, Y., Le Couteur, D., Elliott, PJ, Becker, KG, Navas, P., Ingram, DK, Wolf, NS, Ungvari, Z., Sinclair, DA, ati de Cabo, R. Resveratrol ṣe idaduro ibajẹ ti o jọmọ ọjọ-ori ati pe o ṣe afihan awọn abala kikọ silẹ ti ihamọ ijẹẹmu laisi faagun gigun aye. Cell Metab 2008; 8: 157-168. Wo áljẹbrà.
  92. Dong, W., Li, N., Gao, D., Zhen, H., Zhang, X., ati Li, F. Resveratrol attenuates ibajẹ ọpọlọ ọpọlọ ni apakan ti o pẹ lẹhin ikọlu ati mu ki RNA ojiṣẹ ati amọradagba han fun angiogenic awọn ifosiwewe. J Vasc.Surg. 2008; 48: 709-714. Wo áljẹbrà.
  93. Yu, H. P., Hsu, J. C., Hwang, T. L., Yen, C. H., ati Lau, Y. T. Resveratrol ṣe ipalara ọgbẹ ẹdọ lẹhin ibalokanjẹ-ẹjẹ nipasẹ ọna ti o ni ibatan olugba estrogen. Mọnamọna 2008; 30: 324-328. Wo áljẹbrà.
  94. Bass, T. M., Weinkove, D., Houthoofd, K., Gems, D., ati Partridge, L. Awọn ipa ti resveratrol lori igbesi aye ni Drosophila melanogaster ati Caenorhabditis elegans. Ti dagba Dev 2007; 128: 546-552. Wo áljẹbrà.
  95. Gruber, J., Tang, S. Y., ati Halliwell, B.Ẹri fun iṣowo-ọja laarin iwalaaye ati amọdaju ti o ṣẹlẹ nipasẹ itọju resveratrol ti awọn elegen Caenorhabditis. Ann N Y.Acad Sci 2007; 1100: 530-542. Wo áljẹbrà.
  96. Baur, J. A. ati Sinclair, D. A. Agbara itọju ti resveratrol: ẹri in vivo. Nat Rev Oògùn Discov. 2006; 5: 493-506. Wo áljẹbrà.
  97. Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., ati Cellerino, A. Resveratrol ṣe igbesi aye gigun ati ki o fa idaduro ibẹrẹ ti awọn ami ami ti ọjọ-ori ni pẹpẹ kukuru. Curr Biol 2-7-2006; 16: 296-300. Wo áljẹbrà.
  98. Rakici, O., Kiziltepe, U., Coskun, B., Aslamaci, S., ati Akar, F. Awọn ipa ti resveratrol lori ohun orin ti iṣan ati iṣẹ endothelial ti iṣọn saphenous eniyan ati iṣọn ara inu. Int. J Cardiol 11-2-2005; 105: 209-215. Wo áljẹbrà.
  99. Ma, Z. H. ati Ma, Q. Y. Resveratrol: oogun iṣoogun kan fun pancreatitis nla. World J Gastroenterol. 6-7-2005; 11: 3171-3174. Wo áljẹbrà.
  100. Molnar, V. ati Garai, J. Awọn ohun elo egboogi-iredodo ti o ni ọgbin ti o ni ipa lori iṣẹ tautomerase MIF. Int.Immunopharmacol. 2005; 5: 849-856. Wo áljẹbrà.
  101. Provinciali, M., Re, F., Donnini, A., Orlando, F., Bartozzi, B., Di Stasio, G., ati Smorlesi, A. Ipa ti resveratrol lori idagbasoke awọn èèmọ ọmu laipẹkan ni HER-2 / neu transgenic eku. Int.J Akàn 5-20-2005; 115: 36-45. Wo áljẹbrà.
  102. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., ati Takada, Y. Ipa ti resveratrol ni idena ati itọju ailera ti akàn: iṣaaju ati awọn iwadii ile-iwosan. Anticancer Res. 2004; 24 (5A): 2783-2840. Wo áljẹbrà.
  103. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., ati Walle, U. K. Gbigba giga ṣugbọn bioavailability ti o kere pupọ ti resveratrol roba ninu eniyan. Oògùn Metab Sọ. 2004; 32: 1377-1382. Wo áljẹbrà.
  104. Jannin, B., Menzel, M., Berlot, J. P., Delmas, D., Lancon, A., ati Latruffe, N. Ọkọ ti resveratrol, oluranlowo chemopreventive kan, si awọn ibi-afẹde cellular: isopọ amuaradagba plasmatic ati gbigba sẹẹli. Biochem.Pharmacol. 9-15-2004; 68: 1113-1118. Wo áljẹbrà.
  105. Evers, D. L., Wang, X., Huong, S. M., Huang, D. Y., ati Huang, E. S. 3,4 ’, 5-Trihydroxy-trans-stilbene (resveratrol) lọna atunse cytomegalovirus ti eniyan ati ifihan cellular ti o fa kokoro. Antiviral Res. 2004; 63: 85-95. Wo áljẹbrà.
  106. Piver, B., Fer, M., Vitrac, X., Merillon, JM, Dreano, Y., Berthou, F., ati Lucas, D. Ilowosi ti cytochrome P450 1A2 ninu atunda-aye ti trans-resveratrol ninu ẹdọ eniyan microsomes . Biochem.Pharmacol. 8-15-2004; 68: 773-782. Wo áljẹbrà.
  107. Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., ati Sinclair, D. Awọn oluṣe D. Sirtuin farawe ihamọ caloric ati idaduro ọjọ ogbó ni metazoans. Iseda 8-5-2004; 430: 686-689. Wo áljẹbrà.
  108. Olas, B., Wachowicz, B., Bald, E., ati Glowacki, R. Awọn ipa aabo ti resveratrol lodi si awọn iyipada ninu ẹjẹ thiols ti ẹjẹ pẹlẹpẹlẹ ti a fa nipasẹ awọn agbo ogun Pilatnomu. J.Physiol Pharmacol. 2004; 55: 467-476. Wo áljẹbrà.
  109. Cavallaro, A., Ainis, T., Bottari, C., ati Fimiani, V. Ipa ti resveratrol lori diẹ ninu awọn iṣẹ ti ipinya ati ni gbogbo awọn eniyan ti ko ni ẹjẹ. Idahun Physiol. 2003; 52: 555-562. Wo áljẹbrà.
  110. Kim, YA, Lee, WH, Choi, TH, Rhee, SH, Park, KY, ati Choi, Ilowosi YH ti p21WAF1 / CIP1, pRB, Bax ati NF-kappaB ni ifilọlẹ ti idagba idaduro ati apoptosis nipasẹ resveratrol ninu ẹdọforo ẹdọfóró eniyan Awọn sẹẹli A549. Int.J.Oncol. 2003; 23: 1143-1149. Wo áljẹbrà.
  111. Howitz, KT, Bitterman, KJ, Cohen, HY, Lamming, DW, Lavu, S., Wood, JG, Zipkin, RE, Chung, P., Kisielewski, A., Zhang, LL, Scherer, B., ati Sinclair , DA Awọn oluṣe molikula Kekere ti sirtuins fa gigun aye Saccharomyces cerevisiae. Iseda 9-11-2003; 425: 191-196. Wo áljẹbrà.
  112. Delmas, D., Rebe, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe , N., ati Solary, E. Apoptosis ti o ni ifunni Resveratrol ni nkan ṣe pẹlu atunṣilẹ Fas ninu awọn iṣẹ ọwọ ati dida ipilẹ ami ifasita iku ni awọn sẹẹli akàn ọwọn. J.Biol.Chem. 10-17-2003; 278: 41482-41490. Wo áljẹbrà.
  113. Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y., ati Lin, J. K. Resveratrol-ti o mu G2 mu nipasẹ idinamọ ti CDK7 ati awọn kinisi p34CDC2 ninu awọn sẹẹli HT29 carcinoma. Biochem.Pharmacol. 4-1-2003; 65: 1053-1060. Wo áljẹbrà.
  114. Klinge, C. M., Risinger, K. E., Watts, M. B., Beck, V., Eder, R., ati Jungbauer, A. Iṣẹ iṣe Estrogenic ni awọn iyọkuro waini funfun ati pupa. J Agric. Ounjẹ Chem 3-26-2003; 51: 1850-1857. Wo áljẹbrà.
  115. Vitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., Rosenbaum, J., ati Merillon, JM Pinpin ti [14C] -trans-resveratrol, a polyphenol chemopreventive akàn, ninu awọn awọ eku lẹhin iṣakoso ẹnu. Igbesi aye Sci 4-4-2003; 72: 2219-2233. Wo áljẹbrà.
  116. Levenson, AS, Gehm, BD, Pearce, ST, Horiguchi, J., Simons, LA, Ward, JE, III, Jameson, JL, ati Jordan, VC Resveratrol ṣiṣẹ bi agonist estrogen receptor (ER) ninu awọn sẹẹli aarun igbaya ti yipada pẹlu ER alpha. IntJJ Kàn 5-1-2003; 104: 587-596. Wo áljẹbrà.
  117. Yu, C., Shin, Y. G., Kosmeder, J. W., Pezzuto, J. M., ati van Breemen, R. B. Lirom chromatography / tandem mass spectrometric ipinnu ti itiju ti cytochrome eniyan P450 isozymes nipasẹ resveratrol ati resveratrol-3-imi-ọjọ. Ibaraẹnisọrọ Agbegbe: Mass Spectrom. 2003; 17: 307-313. Wo áljẹbrà.
  118. Olas, B., Wachowicz, B., Saluk-Juszczak, J., ati Zielinski, T. Ipa ti resveratrol, idapọ polyphenolic ti ara, lori ṣiṣisẹ pẹlẹbẹ ti a fa nipasẹ endotoxin tabi thrombin. ThrombRes 8-15-2002; 107 (3-4): 141-145. Wo áljẹbrà.
  119. Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., ati Forstermann, U. Resveratrol, phytoalexin polyphenolic ti o wa ni ọti-waini pupa, mu ikosile ati iṣẹ-ṣiṣe pọ si endothelial nitric oxide synthase. Yika 9-24-2002; 106: 1652-1658. Wo áljẹbrà.
  120. Sharma, M. ati Gupta, Y. K. Itọju onibaje pẹlu trans resveratrol ṣe idiwọ idiwọ imoye intracerebroventricular streptozotocin ati aapọn eero ninu awọn eku. Igbesi aye Sci 10-11-2002; 71: 2489-2498. Wo áljẹbrà.
  121. Holian, O., Wahid, S., Atten, M. J., ati Attar, B. M. Idinamọ ti afikun sẹẹli akàn inu nipa resveratrol: ipa ti ohun elo afẹfẹ nitric. AmJJ Physiol Gastrointest. Nipasẹ Physiol 2002; 282: G809-G816. Wo áljẹbrà.
  122. Potter, GA, Patterson, LH, Wanogho, E., Perry, PJ, Butler, PC, Ijaz, T., Ruparelia, KC, Lamb, JH, Farmer, PB, Stanley, LA, ati Burke, MD Oluranlowo idaabobo akàn resveratrol ti yipada si piceatannol oluranlowo anticancer nipasẹ cytochrome P450 enzymu CYP1B1. Br.J Cancer 3-4-2002; 86: 774-778. Wo áljẹbrà.
  123. Falchetti, R., Fuggetta, M. P., Lanzilli, G., Tricarico, M., ati Ravagnan, G. Awọn ipa ti resveratrol lori iṣẹ sẹẹli alaabo eniyan. Igbesi aye Sci. 11-21-2001; 70: 81-96. Wo áljẹbrà.
  124. Bhavnani, BR, Cecutti, A., Gerulath, A., Woolever, AC, ati Berco, M. Lafiwe ti awọn ipa ẹda ara ti estrogens equine, awọn ẹya waini pupa, Vitamin E, ati probucol lori ijẹẹmu lipoprotein kekere-kekere ni awọn obinrin postmenopausal . Aṣa ọkunrin. 2001; 8: 408-419. Wo áljẹbrà.
  125. Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G., Moon, R. C., ati Pezzuto, J. M. Estrogenic ati awọn ohun-ini antiestrogenic ti resveratrol ni awọn awoṣe tumọ mammary. Akàn Res. 10-15-2001; 61: 7456-7463. Wo áljẹbrà.
  126. Lee, J. E. ati Ailewu, S. Ilowosi ti sisẹ-ifiweranṣẹ-transcriptional ni idinamọ ti ikosile CYP1A1 nipasẹ resveratrol ninu awọn sẹẹli alakan igbaya. Biochem.Pharmacol. 10-15-2001; 62: 1113-1124. Wo áljẹbrà.
  127. Bhat, K. P. ati Pezzuto, J. M. Resveratrol ṣe afihan awọn ohun-ini cytostatic ati antiestrogenic pẹlu awọn sẹẹli adenocarcinoma endometrial (Ishikawa). Akàn Res. 8-15-2001; 61: 6137-6144. Wo áljẹbrà.
  128. Nicolini, G., Rigolio, R., Miloso, M., Bertelli, A. A., ati Tredici, G. Ipa alatako-apoptotic ti trans-resveratrol lori apoptosis ti a fa ni paclitaxel ninu laini sẹẹli neuroblastoma SH-SY5Y. Neurosci. Jẹ ki. 4-13-2001; 302: 41-44. Wo áljẹbrà.
  129. Giovannini, L., Migliori, M., Longoni, BM, Das, DK, Bertelli, AA, Panichi, V., Filippi, C., ati Bertelli, A. Resveratrol, polyphenol kan ti o wa ninu ọti-waini, dinku ipalara isperia isperia ni eku abo. J Cardiovasc.Pharmacol. 2001; 37: 262-270. Wo áljẹbrà.
  130. Chan, W. K. ati Delucchi, A. B. Resveratrol, ẹgbẹ ọti-waini pupa, jẹ inactivator ti o da lori siseto ti cytochrome P450 3A4. Igbesi aye Sci 11-10-2000; 67: 3103-3112. Wo áljẹbrà.
  131. Wang, M. J., Huang, H. M., Hsieh, S. J., Jeng, K. C., ati Kuo, J. S. Resveratrol ṣe idiwọ iṣelọpọ interleukin-6 ni awọn sẹẹli glial ti a dapọ kortical labẹ hypoxia / hypoglycemia atẹle nipa reoxygenation. J Neuroimmunol. 1-1-2001; 112 (1-2): 28-34. Wo áljẹbrà.
  132. Chang, T. K., Lee, W. B., ati Ko, H. H. Trans-resveratrol ṣe atunṣe iṣẹ katalitiki ati ifihan mRNA ti procarcinogen-ṣiṣẹ eniyan cytochrome P450 1B1. Le. J. Physiol Pharmacol. 2000; 78: 874-881. Wo áljẹbrà.
  133. Burkitt, M. J. ati Duncan, J. Awọn ipa ti trans-resveratrol lori igbẹkẹle hydroxyl-radical Ibiyi ati ibajẹ DNA: ẹri fun ṣiṣan hydroxyl-radical ati iwe-akọọlẹ kan, ilana fifipamọ glutathione ti iṣe. Aaki.Biochem.Biophys. 9-15-2000; 381: 253-263. Wo áljẹbrà.
  134. Zbikowska, H. M. ati Olas, B. Awọn antioxidants pẹlu iṣẹ carcinostatic (resveratrol, Vitamin E ati selenium) ni iṣatunṣe ti isomọ platelet ẹjẹ. J Physiol Pharmacol. 2000; 51: 513-520. Wo áljẹbrà.
  135. Kirk, R. I., Deitch, J. A., Wu, J. M., ati Lerea, K. M. Resveratrol dinku awọn iṣẹlẹ ifihan ni kutukutu ninu awọn platelets ti a wẹ ṣugbọn ko ni ipa diẹ lori platalet ni gbogbo ounjẹ. Awọn Ẹjẹ Ẹjẹ Mol.Dis. 2000; 26: 144-150. Wo áljẹbrà.
  136. Bagchi, D., Bagchi, M., Stohs, S. J., Das, D. K., Ray, S. D., Kuszynski, C. A., Joshi, S. S., ati Pruess, H. G. Awọn ipilẹṣẹ ọfẹ ati iru eso ajara proanthocyanidin jade: pataki ni ilera eniyan ati idena arun. Toxicology 8-7-2000; 148 (2-3): 187-197. Wo áljẹbrà.
  137. Bradamante, S., Piccinini, F., Barenghi, L., Bertelli, A. A., De Jonge, R., Beemster, P., ati De Jong, J. W. Ṣe resveratrol n mu ki ilana iṣoogun ṣe? Imudara Ẹya Int.J. 2000; 22: 1-4. Wo áljẹbrà.
  138. Naderali, E. K., Doyle, P. J., ati Williams, G. Resveratrol ṣe ifasita vasorelaxation ti mesenteric ati awọn iṣọn-ara ile lati awọn ẹlẹdẹ ẹlẹdẹ abo. Ile-iwosan Sci (Lond) 2000; 98: 537-543. Wo áljẹbrà.
  139. Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., Kelly, J. W., ati Sacchettini, J. C. Aṣa onipin ti awọn alamọda arun transthyretin amyloid ti o lagbara. Nat Struct.Biol. 2000; 7: 312-321. Wo áljẹbrà.
  140. Martinez, J. ati Moreno, J. J. Ipa ti resveratrol, idapọ polyphenolic ti ara, lori awọn eefun atẹgun ifaseyin ati iṣelọpọ prostaglandin. Biochem. Pharmacol 4-1-2000; 59: 865-870. Wo áljẹbrà.
  141. Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T., Telang, N., ati Dannenberg, A. J. Resveratrol ṣe idiwọ igbasilẹ cyclooxygenase-2 ninu awọn sẹẹli epithelial mammary eniyan. Ann.N.Y.Acad.Sci. 1999; 889: 214-223. Wo áljẹbrà.
  142. Dobrydneva, Y., Williams, R. L., ati Blackmore, P. F. trans-Resveratrol ṣe idiwọ iṣan kalisiomu ninu awọn platelets ti o ni iwuri eniyan. Br.J. Pharmacol. 1999; 128: 149-157. Wo áljẹbrà.
  143. Ciolino, H. P. ati Yeh, G. C. Idinamọ ti iṣẹ-ṣiṣe enzymu P-450 1A1 cytochrome ti o ni ifunni aryl hydrocarbon ati ikosile CYP1A1 nipasẹ resveratrol. Mol.Pharmacol. 1999; 56: 760-767. Wo áljẹbrà.
  144. Lin, J. K. ati Tsai, S. H. Chemoprevention ti akàn ati arun inu ọkan ati ẹjẹ nipa resveratrol. Proc.Natl.Sci.Counc.Repub.China B 1999; 23: 99-106. Wo áljẹbrà.
  145. Zou, J. G., Huang, Y. Z., Chen, Q., Wei, E. H., Hsieh, T. C., ati Wu, J. M. Resveratrol ṣe idiwọ ion ion ti a fa ati iyipada apọju ti apọju ti iwuwo kekere iwuwo eniyan. Biochem.Mol.Biol.Int. 1999; 47: 1089-1096. Wo áljẹbrà.
  146. Rahman, I. Awọn ilọsiwaju itọju Antioxidant ni COPD. Ther.Adv.Respir.Dis. 2008; 2: 351-374. Wo áljẹbrà.
  147. Kimura, Y., Okuda, H., ati Kubo, M. Awọn ipa ti awọn stilbenes ti ya sọtọ lati awọn ohun ọgbin oogun lori iṣelọpọ arachidonate ati degranulation ninu awọn leukocytes polymorphonuclear eniyan. J Ethnopharmacol. 1995; 45: 131-139. Wo áljẹbrà.
  148. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Garcia-Almagro, FJ, Aviles-Plaza, F., Parra, S., Yanez-Gascon, MJ, Ruiz-Ros, JA, Garcia-Conesa , MT, Tomas-Barberan, FA, ati Espin, JC Agbara ti afikun eso ajara ti o ni resveratrol dinku LDL ti o ni ifunni ati ApoB ni awọn alaisan ti o ngba idena akọkọ ti arun inu ọkan ati ẹjẹ: afọju mẹta, atẹle oṣu mẹfa, iṣakoso ibi-iṣakoso , Iwadii ti a sọtọ. Mol Nutr Ounjẹ Ounjẹ 2012; 56: 810-821. Wo áljẹbrà.
  149. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, MJ, Garcia-Almagro, FJ, Ruiz-Ros, JA, Garcia-Conesa, MT, Tomas-Barberan, FA, ati Espin, JC Agbara ọdun kan ti eso-ajara eso ajara ti o ni resveratrol ṣe ilọsiwaju iredodo ati ipo fibrinolytic ti awọn alaisan ni idena akọkọ ti arun inu ọkan ati ẹjẹ. Am J Cardiol. 8-1-2012; 110: 356-363. Wo áljẹbrà.
  150. Zern, TL, Wood, RJ, Greene, C., West, KL, Liu, Y., Aggarwal, D., Shachter, NS, ati Fernandez, ML Grape polyphenols ṣe ipa ipa ti iṣọn-ẹjẹ ni iṣaaju- ati awọn obinrin ti o fiweranṣẹ lẹhin fifi pilasima silẹ lipids ati idinku wahala ipanilara. J Nutr. 2005; 135: 1911-1917. Wo áljẹbrà.
  151. Piver, B., Berthou, F., Dreano, Y., ati Lucas, D. Imukuro iyatọ ti cytochrome P450 enzymes eniyan nipasẹ epsilon-viniferin, dimer ti resveratrol: lafiwe pẹlu resveratrol ati polyphenols lati awọn ohun mimu mimu. Igbesi aye Sci. 7-18-2003; 73: 1199-1213. Wo áljẹbrà.
  152. de, Santi C., Pietrabissa, A., Mosca, F., ati Pacifici, G. M. Glucuronidation ti resveratrol, ọja abayọ ti o wa ninu eso ajara ati ọti-waini, ninu ẹdọ eniyan. Xenobiotica 2000; 30: 1047-1054. Wo áljẹbrà.
  153. Rosa, F. T., Zulet, M. A., Marchini, J. S., ati Martinez, J. A. Awọn agbo ogun bioactive pẹlu awọn ipa lori awọn ami ami iredodo ninu eniyan. Int J Ounjẹ Sci Nutr 2012; 63: 749-765. Wo áljẹbrà.
  154. Chang, T. K., Chen, J., ati Lee, W. B. Iyatọ iyatọ ati inactivation ti awọn enzymu CYP1 eniyan nipasẹ trans-resveratrol: ẹri fun inactivation orisun-ẹrọ ti CYP1A2. J.Pharmacol.Exp.Ther. 2001; 299: 874-882. Wo áljẹbrà.
  155. Ni ipilẹṣẹ, J. P., Marre-Fournier, F., Le Bail, J. C., Habrioux, G., ati Chulia, A. J. Estrogenic / antiestrogenic ati awọn ohun elo fifẹ ti (E) - ati (Z) -resveratrol. Igbesi aye Sci. 1-21-2000; 66: 769-777. Wo áljẹbrà.
  156. Mueller SO, Simon S, Chae K, et al. Phytoestrogens ati awọn iṣelọpọ ara eniyan wọn ṣe afihan agonistic ọtọtọ ati awọn ohun-ini atakoko lori estrogen receptor alpha (ERalpha) ati ERbeta ninu awọn sẹẹli eniyan. Toxicol Sci 2004; 80: 14-25. Wo áljẹbrà.
  157. Boocock DJ, Faust GE, Patel KR, et al. Ipele I iwọn lilo imularada oogun-oogun-oogun ni awọn oluyọọda ilera ti resveratrol, oluranlowo aarun akàn ti o le jẹ alamọ. Aarun Epidemiol Biomarkers Prev 2007; 16: 1246-52. Wo áljẹbrà.
  158. Lyons MM, Yu C, Toma RB, et al. Resveratrol ni aise ati ki o ndin blueberries ati bilberries. J Agric Ounjẹ Chem 2003; 51: 5867-70. Wo áljẹbrà.
  159. Trincheri NF, Nicotra G, Follo C, et al. Resveratrol n fa iku sẹẹli ni awọn sẹẹli akàn awọ nipa ọna aramada ti o kan lysosomal cathepsin D. Carcinogenesis 2007; 28: 922-31. Wo áljẹbrà.
  160. Scarlatti F, Sala G, Somenzi G, et al. Resveratrol n fa idena idagba ati apoptosis ninu awọn sẹẹli aarun igbaya metastatic nipasẹ ifihan ifihan de novo ceramide. FASEB J 2003; 17: 2339-41. Wo áljẹbrà.
  161. Wang Q, Li H, Wang XW, ati al. Resveratrol nse igbega iyatọ ati fa apoptosis ominira-ominira ti awọn sẹẹli medulloblastoma eniyan. Neurosci Lett 2003; 351: 83-6. Wo áljẹbrà.
  162. Culpitt SV, Rogers DF, Fenwick PS, et al. Idinamọ nipasẹ jade waini pupa, resveratrol, ti itusilẹ cytokine nipasẹ awọn macrophages alveolar ni COPD. Thorax 2003; 58: 942-6. Wo áljẹbrà.
  163. Pervaiz S. Resveratrol: lati awọn eso ajara si isedale ti ẹranko. FASEB J 2003; 17: 1975-85. Wo áljẹbrà.
  164. Savaskan E, Olivieri G, Meier F, et al. Ẹrọ resveratrol ọti-waini pupa ṣe aabo lati beta-amyloid neurotoxicity. Gerontology 2003; 49: 380-3. Wo áljẹbrà.
  165. Gao X, Deeb D, Media J, et al. Iṣẹ iṣe ti imunomodulatory ti resveratrol: aibikita ninu vitro ati ni awọn ipa imunola ni vivo. Biochem Pharmacol 2003; 66: 2427-35. Wo áljẹbrà.
  166. Schriever C, Pendland SL, Mahady GB. Ọti-waini pupa, resveratrol, pneumoniae Chlamydia ati asopọ Faranse. Atherosclerosis 2003; 171: 379-80. Wo áljẹbrà.
  167. Ziegler CC, Omi ojo L, Whelan J, McEntee MF. Resveratrol onjẹ ko ni ipa lori tumo tumorigenesis ninu awọn eku Apc (Min / +). J Nutr 2004; 134: 5-10. Wo áljẹbrà.
  168. Kim YA, Choi BT, Lee YT, et al. Resveratrol ṣe idiwọ afikun sẹẹli ati fa apoptosis ti ọmu igba-ara ọmọ ara MCF-7. Oncol Rep 2004; 11: 441-6. Wo áljẹbrà.
  169. Zhang Y, Jayaprakasam B, Seeram NP, et al. Iyokuro insulini ati itiju enzymu cyclooxygenase nipasẹ cabernet sauvignon awọn apopọ awọ ara. J Agric Ounjẹ Chem 2004; 52: 228-33. Wo áljẹbrà.
  170. Opipari AW Jr, Tan L, Boitano AE, et al. Resopratrol-induced autophagocytosis ninu awọn sẹẹli akàn ọjẹ. Akàn Res 2004; 64: 696-703. Wo áljẹbrà.
  171. Abou-Zeid LA, El-Mowafy AM. Iyatọ iyatọ ti awọn isomers resveratrol nipasẹ olugba estrogen eniyan-alpha: ẹri idaamu molikula fun isopọ ligand stereoselective. Chirality 2004; 16: 190-5. Wo áljẹbrà.
  172. Meng X, Maliakal P, Lu H, et al. Awọn ipele ito ati pilasima ti resveratrol ati quercetin ninu awọn eniyan, awọn eku, ati awọn eku lẹhin ifunjẹ ti awọn agbo ogun mimọ ati eso eso ajara. J Agric Ounjẹ Chem 2004; 52: 935-42. Wo áljẹbrà.
  173. Hascalik S, Celik O, Turkoz Y, et al. Resveratrol, ọti-waini pupa pupa polyphenol, ṣe aabo lati ibajẹ ischemia-reperfusion ti awọn ovaries. Gynecol Obstet Invest 2004; 57: 218-23. Wo áljẹbrà.
  174. Ahmad KA, Clement MV, Hanif IM, Pervaiz S. Resveratrol ṣe idiwọ apoptosis ti o ni oogun ninu awọn sẹẹli lukimia eniyan nipa ṣiṣẹda miliu intracellular ti ko ni igbasilẹ fun pipa iku. Akàn Res 2004; 64: 1452-9. Wo áljẹbrà.
  175. Li W, Seifert M, Xu Y, Hock B. Iwadi afiwera ti awọn agbara estrogenic ti estradiol, tamoxifen, bisphenol-A ati resveratrol pẹlu meji in vitro bioassays. Ni ayika Int 2004; 30: 329-35. Wo áljẹbrà.
  176. Martin AR, Villegas I, La Casa C, de la Lastra CA. Resveratrol, polyphenol kan ti a ri ninu eso ajara, npa idibajẹ ifunni ati mu apoptosis lọwọ lakoko iredodo iṣọn akun ni awọn eku. Biochem Pharmacol 2004; 67: 1399-410. Wo áljẹbrà.
  177. Szewczuk LM, Forti L, Stivala LA, Penning TM.Resveratrol jẹ inactivator ti o ni ilaja ti peroxidase ti COX-1 ṣugbọn kii ṣe COX-2: Ọna ọna ẹrọ si apẹrẹ awọn aṣoju yiyan COX-1. J Biol Chem 2004; 279: 22727-37. Wo áljẹbrà.
  178. Wang Z, Huang Y, Zou J, et al. Awọn ipa ti ọti pupa ati ọti-waini polyphenol resveratrol lori ikojọpọ platelet ni vivo ati in vitro. Int J Mol Med 2002; 9: 77-9. Wo áljẹbrà.
  179. Mokni M, Limam F, Elkahoui S, et al. Ipa cardioprotective ti o lagbara ti resveratrol, ọti-waini pupa pupa, lori awọn ọkan eku ti o ya sọtọ lẹhin ipalara ischemia / reperfusion. Arch Biochem Biophys 2007; 457: 1-6. Wo áljẹbrà.
  180. Elmali N, Baysal O, Harma A, et al. Awọn ipa ti resveratrol ni arthritis iredodo. Iredodo 2007; 30: 1-6. Wo áljẹbrà.
  181. Bujanda L, Garcia-Barcina M, Gutierrez-de Juan V, et al. Ipa ti resveratrol lori iku ti o fa ọti-lile ati awọn ọgbẹ ẹdọ ninu awọn eku. BMC Gastroenterol 2006; 6: 35. Wo áljẹbrà.
  182. Baur JA, Pearson KJ, Iye NL, ati al. Resveratrol ṣe ilọsiwaju ilera ati iwalaaye ti awọn eku lori ounjẹ kalori giga kan. Iseda 2006; 444: 337-42. Wo áljẹbrà.
  183. Murias M, Olutọju N, Erker T, et al. Awọn analogues Resveratrol bi yiyan awọn onigbọwọ cyclooxygenase-2: isopọ ati ibatan iṣẹ iṣe. Bioorg Med Chem 2004; 12: 5571-8. Wo áljẹbrà.
  184. Hwang D, Fischer NH, Jang BC, et al. Idinamọ ti ikosile ti cyclooxygenase inducible ati awọn cytokinin proinflammatory nipasẹ sesquiterpene lactones ni awọn macrophages ṣe atunṣe pẹlu idinamọ awọn kinase MAP. Biochem Biophys Res Commun 1996; 226: 810-8 .. Wo áljẹbrà.
  185. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Awọn aṣoju egboogi-aiṣedede ti ko ni iyatọ ninu agbara wọn lati dinku ifilọlẹ NF-kappaB, idinamọ ti ikosile ti cyclooxygenase-2 ati cyclin D1, ati abrogation ti afikun ẹyin tumọ. Oncogene 2004; 23: 9247-58. Wo áljẹbrà.
  186. Goldberg DM, Yan J, Soleas GJ. Gbigba awọn polyphenols ti o ni ibatan ọti-waini mẹta ni awọn matric oriṣiriṣi mẹta nipasẹ awọn akọle ilera. Iwosan Biochem 2003; 36: 79-87 .. Wo áljẹbrà.
  187. Docherty JJ, Fu MM, Stiffler BS, et al. Idinamọ Resveratrol ti idapọ ọlọjẹ herpes simplex. Antiviral Res 1999; 43: 145-55. Wo áljẹbrà.
  188. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol ṣiṣẹ bi agonist / alatako adalu fun awọn olugba estrogen alpha ati beta. Endocrinology 2000; 141: 3657-67.
  189. Piver B, Berthou F, Dreano Y, Lucas D. Idinamọ ti awọn iṣẹ CYP3A, CYP1A ati CYP2E1 nipasẹ resveratrol ati awọn paati ọti pupa pupa miiran ti ko ni iyipada. Toxicol Lett 2001; 125: 83-91. Wo áljẹbrà.
  190. Laden BP, Porter TD. Resveratrol ṣe idiwọ monooxygenase squalene eniyan. Nutr Res 2001; 21: 747-53.
  191. Kozuki Y, Miura Y, Yagasaki K. Resveratrol ṣe idawọle ikọlu sẹẹli hepatoma ni ominira ti iṣe ti egboogi-itankale. Cancer Lett 2001; 167: 151-6. Wo áljẹbrà.
  192. Schneider Y, Vincent F, Duranton B, et al. Ipa alatako-proliferative ti resveratrol, paati adaṣe ti awọn eso ajara ati ọti-waini, lori awọn sẹẹli akàn eniyan. Lett Akàn 2000; 158: 85-91.
  193. Jacobson JS, Troxel AB, Evans J, et al. Iwadii ti a sọtọ ti cohosh dudu fun itọju awọn itanna to gbona laarin awọn obinrin pẹlu itan-akàn ọyan. J Ile-iwosan Oncol 2001; 19: 2739-45. Wo áljẹbrà.
  194. Holmes-McNary M, Baldwin AS, Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Akàn Res 2000; 60: 3477-83. Wo áljẹbrà.
  195. Bertelli AA, Giovannini L, Giannessi D, et al. Iṣẹ Antiplatelet ti iṣelọpọ ati resveratrol adayeba ni ọti-waini pupa. Int J Tissue Atunṣe 1995; 17: 1-3. Wo áljẹbrà.
  196. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, idapọ polyphenolic ti o wa ninu eso ajara ati ọti-waini, jẹ agonist fun olugba estrogen. Proc Natl Acad Sci U S A 1997; 94: 14138-43. Wo áljẹbrà.
  197. Carbo N, Costelli P, Baccino FM, et al. Resveratrol, ọja abayọ kan ti o wa ninu ọti-waini, dinku idagbasoke idagbasoke ninu awoṣe tumọ eku kan. Agbegbe Biochem Biophys Res Commun 1999; 254: 739-43. Wo áljẹbrà.
  198. Huang C, Ma WY, Goranson A, Dong Z. Resveratrol ṣe idinku iyipada sẹẹli ati mu apoptosis ṣiṣẹ nipasẹ ọna-igbẹkẹle p53. Carcinogenesis 1999; 20: 237-42. Wo áljẹbrà.
  199. Davy BM, Melby CL, Beske SD, et al. Agbara Oat ko ni ipa lori isinmi isinmi ati ọkọ alaisan 24-h titẹ ẹjẹ inu ọkan ninu awọn ọkunrin ti o ni titẹ ẹjẹ to gaju deede si ipele I haipatensonu. J Nutr 2002; 132: 394-8 .. Wo áljẹbrà.
  200. Chen CK, Pace-Asciak CR. Iṣẹ iṣe Vasorelaxing ti resveratrol ati quercetin ni ekuro aito eku. Gen Pharmacol 1996; 27: 363-6. Wo áljẹbrà.
  201. Bertelli A, Bertelli AA, Gozzini A, Giovannini L. Plasma ati awọn ifọkansi resveratrol àsopọ ati iṣẹ iṣoogun. Awọn oogun Exp Clin Res Res 1998; 24: 133-8. Wo áljẹbrà.
  202. Pace-Asciak CR, Hahn S, Diamandis EP, ati al. Awọn phenolics waini pupa trans-resveratrol ati quercetin ṣe idiwọ ikojọpọ platelet eniyan ati idapọ eicosanoid: awọn itumọ fun aabo lodi si arun ọkan ọkan ọkan. Iṣẹ iṣe Chim 1995; 235: 207-19. Wo áljẹbrà.
  203. Bertelli AA, Giovannini L, Bernini W, et al. Iṣẹ Antiplatelet ti cis-resveratrol. Awọn oogun Exp Clin Res Res 1996; 22: 61-3. Wo áljẹbrà.
  204. Pace-Asciak CR, Rounova O, Hahn SE, et al. Awọn ọti-waini ati awọn eso eso ajara bi awọn modulators ti ikojọpọ platelet ninu awọn ọmọ eniyan ti o ni ilera. Ile-iṣẹ Chim Acta 1996; 246: 163-82. Wo áljẹbrà.
  205. Jang M, Cai L, Udeani GO, et al. Iṣẹ ṣiṣe chemopreventive ti akàn ti resveratrol, ọja abayọ ti o waye lati eso ajara. Imọ 1997; 275: 218-20. Wo áljẹbrà.
  206. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: molikula kan ti akoko rẹ ti de? Ati pe o lọ? Iwosan Biochem 1997; 30: 91-113. Wo áljẹbrà.
  207. Agri Res Svc: Dokita Duke ti phytochemika ati awọn apoti isura data ethnobotanical. www.ars-grin.gov/duke (Wọle si 3 Kọkànlá Oṣù 1999).
  208. Atunwo ti Awọn ọja Adayeba nipasẹ Awọn Otitọ ati Awọn afiwe. St.Louis, MO: Wolters Kluwer Co., 1999.
  209. Foster S, Tyler VE. Ewebe Onititọ ti Tyler: Itọsọna Oloye si Lilo Awọn Ewebe ati Awọn atunse ibatan. 3rd ed., Binghamton, NY: Haworth Herbal Press, 1993.
  210. Newall CA, Anderson LA, Philpson JD. Oogun oogun: Itọsọna kan fun Awọn akosemose Ilera. London, UK: Ile-iwosan Oogun, 1996.
  211. Tyler VE. Eweko Yiyan. Binghamton, NY: Awọn ọja Oogun Tẹ, 1994.
  212. Blumenthal M, ed. Pipe Igbimọ Jẹmánì E Monographs Pari: Itọsọna Itọju si Awọn Oogun Egbo. Trans. S. Klein. Boston, MA: Igbimọ Botanical ti Amẹrika, 1998.
  213. Monographs lori awọn lilo oogun ti awọn oogun ọgbin. Exeter, UK: European Co-op Phytother Scientific European, 1997.
Atunwo kẹhin - 09/30/2020

Niyanju

Kini idi ti o yẹ ki o da duro sisọ pe o ni aibalẹ Ti o ko ba ṣe gaan
Igbesi Aye

Kini idi ti o yẹ ki o da duro sisọ pe o ni aibalẹ Ti o ko ba ṣe gaan

Gbogbo eniyan ni o jẹbi lilo awọn gbolohun ọrọ ti o ni aifọkanbalẹ fun ipa iyalẹnu: “Emi yoo ni ibajẹ aifọkanbalẹ!” "Eyi n fun mi ni ikọlu ijaya lapapọ ni bayi." Ṣùgbọ́n àwọn ọ̀rọ̀...
Ilera Oṣu Kẹwa, Ifẹ, ati Horoscope Aṣeyọri: Ohun ti Gbogbo Ami nilo lati Mọ
Igbesi Aye

Ilera Oṣu Kẹwa, Ifẹ, ati Horoscope Aṣeyọri: Ohun ti Gbogbo Ami nilo lati Mọ

Awọn gbigbọn Igba Irẹdanu Ewe wa ni ifowo i nibi. O jẹ Oṣu Kẹwa: oṣu kan fun jija awọn weater comfie t rẹ ati awọn bata orunkun ti o wuyi, ti nlọ lori awọn ṣiṣe irọlẹ agaran ti o pe fun hoodie iwuwo f...